ASCO 2020: Biomarkers for immunotherapy treatment for advanced kidney cancer
Biomarkers enable doctors predict which patients will respond to which [...]
Biomarkers enable doctors predict which patients will respond to which [...]
Results from a phase II international trial led by researchers [...]
A study presented during the 2020 American Society of Clinical [...]
Updated results from the KEYNOTE-426 study of pembrolizumab plus axitinib [...]
In a study presented during the 2020 American Society of [...]